HIV/AIDS: Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma–Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease
Open Access
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (9) , 1209-1215
- https://doi.org/10.1086/592298
Abstract
Kaposi sarcoma—associated herpesvirus infection is associated with the development of 3 proliferative diseases: Kaposi sarcoma, primary effusion lympKeywords
This publication has 73 references indexed in Scilit:
- Valganciclovir for Suppression of Human Herpesvirus–8 Replication: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover TrialThe Journal of Infectious Diseases, 2008
- HIV‐associated multicentric Castleman's diseaseAmerican Journal of Hematology, 2008
- More on HIV-Associated Kaposi's SarcomaNew England Journal of Medicine, 2008
- Frequent and Asymptomatic Oropharyngeal Shedding of Human Herpesvirus 8 among Immunocompetent MenThe Journal of Infectious Diseases, 2007
- Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingBlood, 2006
- HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE StudySexually Transmitted Infections, 2006
- Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8Blood, 2005
- Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?The FASEB Journal, 2004
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Idiopathisches multiples Pigmentsarkom der HautArchives of Dermatological Research, 1872